News
Novartis is stopping the development of ianalumab in hidradenitis suppurativa (HS) after a Phase IIb proof-of-concept trial failed to meet its primary endpoint.
The wellness trend is driving demand for functional, protein-rich foods like yogurt. Here’s what’s fueling growth in the ...
Pharmaceutical companies and manufacturers, including MilliporeSigma (Burlington, US), Simtra BioPharma Solutions (Parsippany, US), Carbogen AMCIS (Bubendorf, Switzerland), and BioNTech (Mainz, ...
The shift is driven by stricter regulations, higher material costs, and the need for robust logistics, making reusable packaging essential for modern industry.
7h
Al Jazeera on MSNTesla finally parks in India. But can it survive?Elon Musk’s EV giant has launched its Model Y in Mumbai, but its $70,000 price tag may be its biggest speed bump.
19h
Just Auto on MSNMercedes-Benz brings Microsoft Teams calls to carsMercedes-Benz says it is the first to natively integrate Microsoft Intune into a vehicle operating system, creating a secure workspace on wheels.
Localising and automating supply chains will allow companies to mitigate the impact of tariffs and minimise resulting costs.
Following today’s release of DFS’ figures for the 52 weeks ending 29 June 2025; Matt Walton, senior retail analyst at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results